Skip to main content
. 2022 Sep 30;12:16415. doi: 10.1038/s41598-022-20186-8

Figure 5.

Figure 5

IL-6 secretion from exosome treated fibroblasts. Fibroblasts were exposed to Jurkat cells derived exosomes (Exo) in two different concentrations, to telomerase inhibitor (GRN) or to Jurkat-derived exosomes and telomerase inhibitor (Exo + GRN) for 24 and 48 h. Media was collected and IL-6 protein levels in the supernatants were measured by ELISA. Each column represents mean (%) ± S.E of at least two independent experiments. *Indicates PV < 0.05.